List of Excipients in API TERCONAZOLE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing TERCONAZOLE
Excipients in ANDA-approved (generic) drugs containing TERCONAZOLE
Detailed excipient profiles for TERCONAZOLE
Excipient focus: BUTYLATED HYDROXYANISOLE
TERCONAZOLE drug variants containing BUTYLATED HYDROXYANISOLE
TERCONAZOLE drug variants not containing BUTYLATED HYDROXYANISOLE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CETYL ALCOHOL
TERCONAZOLE drug variants containing CETYL ALCOHOL
TERCONAZOLE drug variants not containing CETYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Cosette Pharmaceuticals Inc | terconazole | 0713-0552 |
| Padagis Israel Pharmaceuticals Ltd | terconazole | 45802-717 |
| Taro Pharmaceuticals USA Inc | terconazole | 51672-1330 |
| >Company | >Ingredient | >NDC |
Excipient focus: COCONUT OIL
TERCONAZOLE drug variants containing COCONUT OIL
| Company | Ingredient | NDC |
|---|---|---|
| Cosette Pharmaceuticals Inc | terconazole | 0713-0552 |
| Taro Pharmaceuticals USA Inc | terconazole | 51672-1330 |
| >Company | >Ingredient | >NDC |
TERCONAZOLE drug variants not containing COCONUT OIL
Excipient focus: ISOPROPYL MYRISTATE
TERCONAZOLE drug variants containing ISOPROPYL MYRISTATE
TERCONAZOLE drug variants not containing ISOPROPYL MYRISTATE
| Company | Ingredient | NDC |
|---|---|---|
| Cosette Pharmaceuticals Inc | terconazole | 0713-0552 |
| Padagis Israel Pharmaceuticals Ltd | terconazole | 45802-717 |
| Taro Pharmaceuticals USA Inc | terconazole | 51672-1330 |
| >Company | >Ingredient | >NDC |
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
TERCONAZOLE drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Padagis Israel Pharmaceuticals Ltd | terconazole | 45802-717 |
| >Company | >Ingredient | >NDC |
TERCONAZOLE drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
Excipient focus: PALM KERNEL OIL
TERCONAZOLE drug variants containing PALM KERNEL OIL
| Company | Ingredient | NDC |
|---|---|---|
| Cosette Pharmaceuticals Inc | terconazole | 0713-0552 |
| Taro Pharmaceuticals USA Inc | terconazole | 51672-1330 |
| >Company | >Ingredient | >NDC |
TERCONAZOLE drug variants not containing PALM KERNEL OIL
Excipient focus: POLYSORBATE 60
TERCONAZOLE drug variants containing POLYSORBATE 60
TERCONAZOLE drug variants not containing POLYSORBATE 60
| Company | Ingredient | NDC |
|---|---|---|
| Cosette Pharmaceuticals Inc | terconazole | 0713-0552 |
| Padagis Israel Pharmaceuticals Ltd | terconazole | 45802-717 |
| Taro Pharmaceuticals USA Inc | terconazole | 51672-1330 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
TERCONAZOLE drug variants containing POLYSORBATE 80
TERCONAZOLE drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Cosette Pharmaceuticals Inc | terconazole | 0713-0552 |
| Padagis Israel Pharmaceuticals Ltd | terconazole | 45802-717 |
| Taro Pharmaceuticals USA Inc | terconazole | 51672-1330 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
TERCONAZOLE drug variants containing PROPYLENE GLYCOL
TERCONAZOLE drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Cosette Pharmaceuticals Inc | terconazole | 0713-0552 |
| Padagis Israel Pharmaceuticals Ltd | terconazole | 45802-717 |
| Taro Pharmaceuticals USA Inc | terconazole | 51672-1330 |
| >Company | >Ingredient | >NDC |
Excipient focus: STEARYL ALCOHOL
TERCONAZOLE drug variants containing STEARYL ALCOHOL
TERCONAZOLE drug variants not containing STEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Cosette Pharmaceuticals Inc | terconazole | 0713-0552 |
| Padagis Israel Pharmaceuticals Ltd | terconazole | 45802-717 |
| Taro Pharmaceuticals USA Inc | terconazole | 51672-1330 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
TERCONAZOLE drug variants containing WATER
TERCONAZOLE drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Cosette Pharmaceuticals Inc | terconazole | 0713-0552 |
| Padagis Israel Pharmaceuticals Ltd | terconazole | 45802-717 |
| Taro Pharmaceuticals USA Inc | terconazole | 51672-1330 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
